Serovera

SEROVERA sells aloe-vera-based dietary supplements aimed at digestive and immune support. Flagship SKUs include AMP 500 mg capsules, powdered drink mixes, and topical gels priced in the premium tier: $150–$200 for a 30-day supply. All distribution is DTC through the brand’s own website; no retail or third-party e-commerce. The company’s point of difference is “Aloe Mucilaginous Polysaccharide” (AMP), a freeze-dried extract it claims is 200× more potent than raw aloe. Every lot is certified organic, non-GMO, and produced in an NSF-registered U.S. facility; third-party lab reports are posted online. The brand positions itself as a clinical-strength, physician-recommended alternative to conventional GI therapies. Core buyers are adults 35-65 managing IBS, Crohn’s, colitis, or post-chemo gut issues; they value drug-free, plant-derived protocols and are willing to pay for high-potency, vertically controlled sourcing. Messaging stresses “restore before you medicate,” resonating with wellness seekers who track biomarkers and follow functional-medicin influencers. SEROVERA competes in the niche of high-dose, condition-specific botanical supplements rather than mass-market aloe juices. It differentiates through patented AMP concentration, medical-practitioner testimonials, and a 90-day empty-bottle guarantee—features mainstream aloe brands and general probiotics rarely match.